• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2005 Fiscal Year Final Research Report Summary

Cell biological study of the RANDAM-2 high positive cells and RANDAM-2 low/negative cells in mouse central nervous system.

Research Project

Project/Area Number 16500252
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Neurochemistry/Neuropharmacology
Research InstitutionOhu University (2005)
Tokyo Metropolitan Organization for Medical Research (2004)

Principal Investigator

KOTANI Masaharu  Ohu University, Pharmaceutical Sciences, Associate Professor, 薬学部, 助教授 (10195737)

Project Period (FY) 2004 – 2005
KeywordsMouse neurospheres / neural stem cells / cell membrane antigens / RANDAM-2 / FACS analysis
Research Abstract

RANDAM-2, a type-I transmembrane antigen constitutively expressed on the excitatory neuronal cell lineage during mouse neurogenesis, shows the highest expression level between embryonic day 8.5 (E8.5) and E10.5. As the period well overlaps with the proliferating stages of neural stem cells (NSCs), it is conceivable that RANDAM-2 is involved in the proliferation and/or the resulting neural differentiation. In this paper, we show that NSCs and NPCs can be isolated as RANDAM-2^<high+> and RANDAM-2^<low+/-> cells, respectively, by positive selection with a monoclonal antibody specific to RANDAM-2. The isolated RANDAM-2^<high+> cells had the characteristics as the highly self-renewal capability and potential for multilineage differentiation into neural cells. In contrast, almost all of the RANDAM-2^<low+/-> cells exhibited not only the extremely low self-renewability but the differentiation capability restricted to neurons. These two cell populations also differed from each other in terms of the expression level of molecules associated with neural differentiation. These findings demonstrate that RANDAM-2 can be regarded as a useful marker for isolation of the NSCs, and suggest that its high expression takes part in the retention of the neural cells within the innate properties as NSCs.

  • Research Products

    (12 results)

All 2005 2004

All Journal Article (12 results)

  • [Journal Article] Distal myopathy with rimmed vacuoles : Impaiered-Ο-glycan formation in sarcoemmal glycoprooteins.2005

    • Author(s)
      Tajima, Y., Uyama, E., Go, S., Sato, C., Tao, N., Kotani, M.et al.
    • Journal Title

      American Journal of Pathology 166

      Pages: 1121-1130

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] Establishment of immortalized Schwann cells from Sandhoff mice and corrective effect of recombinant human beta-hexosaminidase A on the accumulated GM2 ganglioside.2005

    • Author(s)
      Murata, M., Motani, M.et al.
    • Journal Title

      Journal of Human Genetics 50

      Pages: 460-467

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] An asymptomatic heterozygous female with Fabry disease : Implication for enzyme replacement therapy.2005

    • Author(s)
      Inagaki, S., Migita, M., Hayakawa, M., fujita, A., Yoshida, J., Ishizaki, M., Kotani, M.et al.
    • Journal Title

      Journal of Nippon Medical School 72

      Pages: 687-690

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] Distal myopathy with rimmed vacuoles : Impaired O-glycan formation in sarcolemmal glycoproteins.2005

    • Author(s)
      Tajima, Y, Uyama, E., Go, S., Sato, C., Tao, N., Kotani, M., et al.
    • Journal Title

      American Journal of Pathology 166(4)

      Pages: 1121-1130

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Establishment of immortalized Schwann cells from Sandhoff mice and corrective effect of recombinant human beta-hexosaminidase A on the accumulated GM2 ganglioside.2005

    • Author(s)
      Murata, M., Kotani, M., et al.
    • Journal Title

      Journal of Human Genetics 50

      Pages: 460-467

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] An asymptomatic heterozygous female with Fabry disease : Implication for enzyme replacement therapy.2005

    • Author(s)
      Inagaki, S., Migita, M., Hayakawa, M., Fujita, A., Yoshida, J., Ishizaki, M., Kotani, M., et al.
    • Journal Title

      Journal of Nippon Medical School 72(6)

      Pages: 687-690

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Cytochemical and biochemical detection of intracellularly accumulate sialyl glycoconjugates in sialidosis and galactosialidosis fibroblasts with Macckia amurensis.2004

    • Author(s)
      Motegi, A., Fujimoto, J., Kotani, N.et al.
    • Journal Title

      Clinica Chimica Acta 344

      Pages: 131-135

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth.2004

    • Author(s)
      Motegi, A., Fujimoto, J., Kotani, N.et al.
    • Journal Title

      Journal of Cell Science 117

      Pages: 3319-3329

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] Reversibility versus persistence of GPIIb/IIIa blocker-induced conformational change of GP_IIb/III_a (aIIbβ3,CD41/CD61)2004

    • Author(s)
      Schwarz, M., Katagiri, Y., Kotani, M.et al.
    • Journal Title

      Journal of Pharmacology and Experimental Therapeutics 308

      Pages: 1002-1011

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] Cytochemical and biochemical detection of intracellularly accumulate sialyl glycoconjugates in sialidosis and galactosialidosis fibroblasts with Macckia amurensis.2004

    • Author(s)
      Kotani, M., Yamada, H., Sakuraba, H.
    • Journal Title

      Clinica Chimica Acta 344

      Pages: 131-135

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth.2004

    • Author(s)
      Motegi, A., Fujimoto, J., Kotani, M, Sakuraba, H., Yamamoto, T.
    • Journal Title

      Journal of Cell Science 117

      Pages: 3319-3329

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Reversibility versus persistence of GPIIb/IIIa blocker-induced conformational change of GP_<IIb>/III_a (αIIbβ3, CD41/CD61).2004

    • Author(s)
      Schwarz, M., Katagiri, Y, Kotani, M., et al.
    • Journal Title

      Journal of Pharmacology and Experimental Therapeutics 308(3)

      Pages: 1002-1011

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2007-12-13  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi